Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Cross-sectional Study of Regret in Cancer Patients After Sharing Test Results for Pathogenic Germline Variants of Hereditary Cancers With Relatives.
Fukuzaki N, Kiyozumi Y, Higashigawa S, Horiuchi Y, Matsubayashi H, Nishimura S, Mori K, Notsu A, Suishu I, Ohnami S, Kusuhara M, Yamaguchi K, Doorenbos AZ, Takeda Y. Fukuzaki N, et al. Among authors: mori k. Cancer Nurs. 2024 Jul-Aug 01;47(4):281-289. doi: 10.1097/NCC.0000000000001224. Epub 2023 Mar 7. Cancer Nurs. 2024. PMID: 36881649
Preoperative indicators of failure of en bloc resection or perforation in colorectal endoscopic submucosal dissection: implications for lesion stratification by technical difficulties during stepwise training.
Imai K, Hotta K, Yamaguchi Y, Kakushima N, Tanaka M, Takizawa K, Kawata N, Matsubayashi H, Shimoda T, Mori K, Ono H. Imai K, et al. Among authors: mori k. Gastrointest Endosc. 2016 May;83(5):954-62. doi: 10.1016/j.gie.2015.08.024. Epub 2015 Aug 20. Gastrointest Endosc. 2016. PMID: 26297870
Assessment of associations between clinical and immune microenvironmental factors and tumor mutation burden in resected nonsmall cell lung cancer by applying machine learning to whole-slide images.
Ono A, Terada Y, Kawata T, Serizawa M, Isaka M, Kawabata T, Imai T, Mori K, Muramatsu K, Hayashi I, Kenmotsu H, Ohshima K, Urakami K, Nagashima T, Kusuhara M, Akiyama Y, Sugino T, Ohde Y, Yamaguchi K, Takahashi T. Ono A, et al. Among authors: mori k. Cancer Med. 2020 Jul;9(13):4864-4875. doi: 10.1002/cam4.3107. Epub 2020 May 12. Cancer Med. 2020. PMID: 32400056 Free PMC article.
Proposing synchronous oligometastatic non-small-cell lung cancer based on progression after first-line systemic therapy.
Miyawaki T, Wakuda K, Kenmotsu H, Miyawaki E, Mamesaya N, Kobayashi H, Omori S, Ono A, Naito T, Murakami H, Notsu A, Mori K, Harada H, Endo M, Ohde Y, Takahashi K, Takahashi T. Miyawaki T, et al. Among authors: mori k. Cancer Sci. 2021 Jan;112(1):359-368. doi: 10.1111/cas.14707. Epub 2020 Nov 11. Cancer Sci. 2021. PMID: 33098119 Free PMC article.
Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer.
Nishioka N, Naito T, Notsu A, Mori K, Kodama H, Miyawaki E, Miyawaki T, Mamesaya N, Kobayashi H, Omori S, Wakuda K, Ono A, Kenmotsu H, Murakami H, Takayama K, Takahashi T. Nishioka N, et al. Among authors: mori k. Cancer Med. 2021 Jan;10(1):247-256. doi: 10.1002/cam4.3631. Epub 2020 Dec 10. Cancer Med. 2021. PMID: 33300678 Free PMC article.
7,608 results